Brief: Syros Presents New Data From Phase 1 Trial Of Sy-5609

Syros Pharmaceuticals

20/09/2021 17:39

Sept 20 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS PRESENTS NEW DATA FROM PHASE 1 TRIAL OF SY-5609 AND DETAILS
THREE-PRONGED
COMBINATION STRATEGY TO ADVANCE SY-5609 IN SOLID TUMORS AND BLOOD CANCER
    * SYROS PHARMACEUTICALS INC - UPDATED DOSE-ESCALATION DATA DEMONSTRATE
CLINICAL
ACTIVITY IN HEAVILY PRE-TREATED PATIENTS ACROSS MULTIPLE TUMOR TYPES

Source text for Eikon:  ID:nBw6C1z2La 
Further company coverage:  SYRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))